{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05077280",
            "orgStudyIdInfo": {
                "id": "2021.072-2"
            },
            "organization": {
                "fullName": "California Pacific Medical Center Research Institute",
                "class": "OTHER"
            },
            "briefTitle": "A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma",
            "officialTitle": "A Phase II Study of Concurrent Stereotactic Body Radiotherapy With Relatlimab and Nivolumab in Patients With Metastatic Uveal Melanoma",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "a-study-of-concurrent-stereotactic-body-radiotherapy-with-opdualag-in-metastatic-uveal-melanoma"
        },
        "statusModule": {
            "statusVerifiedDate": "2022-12",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-09-20",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-03",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-03",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-10-05",
            "studyFirstSubmitQcDate": "2021-10-05",
            "studyFirstPostDateStruct": {
                "date": "2021-10-14",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2022-12-02",
            "lastUpdatePostDateStruct": {
                "date": "2022-12-06",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "California Pacific Medical Center Research Institute",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "This is a phase 2 trial of concurrent stereotactic radiation therapy (SBRT) with immunotherapy with relatlimab and nivolumab for up to two years. SBRT will be given in three doses of 15Gy each to 1-5 separate metastases. Opdualag (nivolumab 480mg and relatlimab 160mg) will be given every 4 weeks for two years",
            "detailedDescription": "Metastatic uveal melanoma has no standard therapy, but there is evidence that both radiation therapy and immunotherapy may be helpful and may be synergistic. This is a phase 2 trial of concurrent stereotactic radiation therapy (SBRT) with immunotherapy with Opdualag (nivolumab 480mg and relatlimab 160mg) for up to two years. SBRT will be given in three doses of 15Gy each to 1-5 separate metastases, limiting the total dosage to 700cc's of normal liver to \\<15Gy. Opdualag (nivolumab 480mg and relatlimab 160mg) will be given every 4 weeks for two years. Objectives are to determine the safety and tolerability, and iRECIST will be used to determine responses.We will treat up to 50 patients."
        },
        "conditionsModule": {
            "conditions": [
                "Uveal Melanoma"
            ],
            "keywords": [
                "metastatic"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 40,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "one arm",
                    "type": "EXPERIMENTAL",
                    "description": "see below",
                    "interventionNames": [
                        "Radiation: stereotactic body radiotherapy",
                        "Drug: Immunotherapy"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "RADIATION",
                    "name": "stereotactic body radiotherapy",
                    "description": "Stereotactic Body radiotherapy will be given to 1-5 target metastases in 3 doses over 8 days or less. Each dose will be 15Gy for a total dose of 45GY",
                    "armGroupLabels": [
                        "one arm"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Immunotherapy",
                    "description": "Opdualag (nivolumab 480mg and relatlimab 160mg) will be given every 4 weeks for two years",
                    "armGroupLabels": [
                        "one arm"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "safety and tolerability of the therapy",
                    "description": "toxicity measured by CTAE graded 3-5 toxicities",
                    "timeFrame": "5 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Response rate",
                    "description": "iRECIST defined response rates",
                    "timeFrame": "5 years"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Progression-free survival",
                    "description": "survival without progressive cancer",
                    "timeFrame": "5 years"
                },
                {
                    "measure": "Overall survival",
                    "description": "survival",
                    "timeFrame": "5 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* measurable metastatic uveal melanoma.\n* No concomitant therapy.\n* Prior PD1 or tebendafesp allowed.\n* Performance status 0-1.\n* No active Hepatitis B.\n* No known HIV infection.\n* WBC\\>2000, ANC\\>1500, Hgb \\>8.\n* Creatinine \\< 3 x ULN.\n* AST \\& ALT \\< 2.5 x ULN Bilirubin \\< 2 x ULN.\n* Albumin \\>2.9\n\nExclusion Criteria:\n\n* Liver tumor volume \\> 50%.\n* Active CNS metastases.\n* Pregnancy.\n* Prior therapy with Opdualag or relatlimab\n* Certain autoimmune diseases.\n* Previous liver embolization or radiation.\n* Use of systemic steroids",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Madeline Decker",
                    "role": "CONTACT",
                    "phone": "4156006000",
                    "email": "KimKB@sutterhealth.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "David R Minor, MD",
                    "affiliation": "California Pacific Med Center Research Inst.",
                    "role": "STUDY_CHAIR"
                }
            ],
            "locations": [
                {
                    "facility": "California Pacific Medical Center Research Institute",
                    "status": "RECRUITING",
                    "city": "San Francisco",
                    "state": "California",
                    "zip": "94115",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Madeline Decker",
                            "role": "CONTACT",
                            "phone": "415-600-3613",
                            "email": "KimB@sutterhealth.org"
                        },
                        {
                            "name": "Kevin B Kim, M.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.77493,
                        "lon": -122.41942
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008545",
                    "term": "Melanoma"
                },
                {
                    "id": "D000014604",
                    "term": "Uveal Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000018358",
                    "term": "Neuroendocrine Tumors"
                },
                {
                    "id": "D000017599",
                    "term": "Neuroectodermal Tumors"
                },
                {
                    "id": "D000009373",
                    "term": "Neoplasms, Germ Cell and Embryonal"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000009380",
                    "term": "Neoplasms, Nerve Tissue"
                },
                {
                    "id": "D000018326",
                    "term": "Nevi and Melanomas"
                },
                {
                    "id": "D000012878",
                    "term": "Skin Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                },
                {
                    "id": "D000005134",
                    "term": "Eye Neoplasms"
                },
                {
                    "id": "D000005128",
                    "term": "Eye Diseases"
                },
                {
                    "id": "D000014603",
                    "term": "Uveal Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11528",
                    "name": "Melanoma",
                    "asFound": "Melanoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17352",
                    "name": "Uveal Neoplasms",
                    "asFound": "Uveal Melanoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M20495",
                    "name": "Neuroendocrine Tumors",
                    "relevance": "LOW"
                },
                {
                    "id": "M19845",
                    "name": "Neuroectodermal Tumors",
                    "relevance": "LOW"
                },
                {
                    "id": "M20388",
                    "name": "Neuroectodermal Tumors, Primitive",
                    "relevance": "LOW"
                },
                {
                    "id": "M12318",
                    "name": "Neoplasms, Germ Cell and Embryonal",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M12325",
                    "name": "Neoplasms, Nerve Tissue",
                    "relevance": "LOW"
                },
                {
                    "id": "M12448",
                    "name": "Nevus, Pigmented",
                    "relevance": "LOW"
                },
                {
                    "id": "M12446",
                    "name": "Nevus",
                    "relevance": "LOW"
                },
                {
                    "id": "M20470",
                    "name": "Nevi and Melanomas",
                    "relevance": "LOW"
                },
                {
                    "id": "M15681",
                    "name": "Skin Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8277",
                    "name": "Eye Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8271",
                    "name": "Eye Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17351",
                    "name": "Uveal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T3099",
                    "name": "Intraocular Melanoma",
                    "asFound": "Uveal Melanoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4091",
                    "name": "Neuroendocrine Tumor",
                    "relevance": "LOW"
                },
                {
                    "id": "T4092",
                    "name": "Neuroepithelioma",
                    "relevance": "LOW"
                },
                {
                    "id": "T5824",
                    "name": "Uveal Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC11",
                    "name": "Eye Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000091369",
                    "term": "Immunomodulating Agents"
                }
            ],
            "ancestors": [
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M2853",
                    "name": "Immunomodulating Agents",
                    "asFound": "Modules",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1854",
                    "name": "Nivolumab",
                    "relevance": "LOW"
                },
                {
                    "id": "M354150",
                    "name": "Relatlimab",
                    "relevance": "LOW"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                }
            ]
        }
    },
    "hasResults": false
}